Overprescription of short-acting β2 agonists: reflections from the SABINA study in Brazil
ABSTRACT Objective: To assess prescription patterns for short-acting b2 agonists (SABAs) and other asthma medications in asthma patients treated by specialists and participating in the SABA use IN Asthma (SABINA) study in Brazil. Methods: This was an observational, cross-sectional study conducted at five sites in different regions of Brazil. The primary endpoints were to record SABA prescriptions and obtain data on over-the-counter (OTC) SABA purchases at the pharmacy. Results: Data on 218 asthma patients were analyzed. Of those 218 patients, 80.3% were prescribed SABAs in addition to their maintenance therapy, with a mean of 11.2 SABA canisters in the previous 12 months. Of those patients, 71.4% were prescribed ≥ 3 canisters and 42.2% were prescribed ≥ 10 canisters. None of the patients were prescribed SABA monotherapy. A total of 14.2% of the patients reported purchasing SABAs OTC at a pharmacy without a prescription. Of those, 48.4% purchased ≥ 3 SABA canisters. A fixed-dose combination of an inhaled corticosteroid and a long-acting b2 agonist was prescribed to 95.0% of the patients. In the year before the study visit, 45.0% of the patients received at least one course of oral corticosteroid burst treatment. Asthma was well controlled in 43.1% of the patients, partly controlled in 34.9%, and uncontrolled in 22.0%. Patients reported a mean of 1.1 severe asthma exacerbations, with 49.1% experiencing 1 or more severe exacerbations. Conclusions: Overprescription and OTC purchases of SABAs are common in Brazil, possibly leading to the need for courses of oral corticosteroids. The health care community should collaborate to implement evidence-based recommendations and promote health education to improve asthma management in Brazil..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
Jornal Brasileiro de Pneumologia - 50(2024), 1 |
| Sprache: |
Englisch ; Portugiesisch |
|---|
| Beteiligte Personen: |
Martti Anton Antila [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Asthma |
|---|
| doi: |
10.36416/1806-3756/e20230174 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ092830684 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ092830684 | ||
| 003 | DE-627 | ||
| 005 | 20240413111013.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240412s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.36416/1806-3756/e20230174 |2 doi | |
| 035 | |a (DE-627)DOAJ092830684 | ||
| 035 | |a (DE-599)DOAJ069434d4cd444bd094926b7c70e77733 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a por | ||
| 050 | 0 | |a RC705-779 | |
| 100 | 0 | |a Martti Anton Antila |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Overprescription of short-acting β2 agonists: reflections from the SABINA study in Brazil |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ABSTRACT Objective: To assess prescription patterns for short-acting b2 agonists (SABAs) and other asthma medications in asthma patients treated by specialists and participating in the SABA use IN Asthma (SABINA) study in Brazil. Methods: This was an observational, cross-sectional study conducted at five sites in different regions of Brazil. The primary endpoints were to record SABA prescriptions and obtain data on over-the-counter (OTC) SABA purchases at the pharmacy. Results: Data on 218 asthma patients were analyzed. Of those 218 patients, 80.3% were prescribed SABAs in addition to their maintenance therapy, with a mean of 11.2 SABA canisters in the previous 12 months. Of those patients, 71.4% were prescribed ≥ 3 canisters and 42.2% were prescribed ≥ 10 canisters. None of the patients were prescribed SABA monotherapy. A total of 14.2% of the patients reported purchasing SABAs OTC at a pharmacy without a prescription. Of those, 48.4% purchased ≥ 3 SABA canisters. A fixed-dose combination of an inhaled corticosteroid and a long-acting b2 agonist was prescribed to 95.0% of the patients. In the year before the study visit, 45.0% of the patients received at least one course of oral corticosteroid burst treatment. Asthma was well controlled in 43.1% of the patients, partly controlled in 34.9%, and uncontrolled in 22.0%. Patients reported a mean of 1.1 severe asthma exacerbations, with 49.1% experiencing 1 or more severe exacerbations. Conclusions: Overprescription and OTC purchases of SABAs are common in Brazil, possibly leading to the need for courses of oral corticosteroids. The health care community should collaborate to implement evidence-based recommendations and promote health education to improve asthma management in Brazil. | ||
| 650 | 4 | |a Asthma | |
| 650 | 4 | |a Brazil | |
| 650 | 4 | |a Bronchodilator agents | |
| 650 | 4 | |a Prescriptions | |
| 653 | 0 | |a Diseases of the respiratory system | |
| 700 | 0 | |a Adelmir Souza-Machado |e verfasserin |4 aut | |
| 700 | 0 | |a Marcelo Gervilla Gregório |e verfasserin |4 aut | |
| 700 | 0 | |a Álvaro A Cruz |e verfasserin |4 aut | |
| 700 | 0 | |a Luciene Angelini |e verfasserin |4 aut | |
| 700 | 0 | |a Maarten J H I Beekman |e verfasserin |4 aut | |
| 700 | 0 | |a Gilmar Alves Zonzin |e verfasserin |4 aut | |
| 700 | 0 | |a Marcelo Fouad Rabahi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Jornal Brasileiro de Pneumologia |d Sociedade Brasileira de Pneumologia e Tisiologia, 2005 |g 50(2024), 1 |w (DE-627)DOAJ000136387 |x 18063756 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2024 |g number:1 |
| 856 | 4 | 0 | |u https://doi.org/10.36416/1806-3756/e20230174 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/069434d4cd444bd094926b7c70e77733 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132024000100601&tlng=en |z kostenfrei |
| 856 | 4 | 0 | |u http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132024000100601&tlng=pt |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1806-3756 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2024 |e 1 | ||